China · Delayed Price · Currency is CNY Jianerkang Medical Statistics
Total Valuation
SHA:603205 has a market cap or net worth of CNY 4.37 billion. The enterprise value is 3.65 billion.
| Market Cap | 4.37B |
| Enterprise Value | 3.65B |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603205 has 156.00 million shares outstanding. The number of shares has increased by 30.14% in one year.
| Current Share Class | 156.00M |
| Shares Outstanding | 156.00M |
| Shares Change (YoY) | +30.14% |
| Shares Change (QoQ) | +1.68% |
| Owned by Insiders (%) | 66.00% |
| Owned by Institutions (%) | 1.02% |
| Float | 41.34M |
Valuation Ratios
The trailing PE ratio is 41.37.
| PE Ratio | 41.37 |
| Forward PE | n/a |
| PS Ratio | 4.42 |
| PB Ratio | 3.00 |
| P/TBV Ratio | 3.12 |
| P/FCF Ratio | 54.55 |
| P/OCF Ratio | 31.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.07, with an EV/FCF ratio of 45.63.
| EV / Earnings | 35.43 |
| EV / Sales | 3.70 |
| EV / EBITDA | 25.07 |
| EV / EBIT | 35.79 |
| EV / FCF | 45.63 |
Financial Position
The company has a current ratio of 8.30, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.30 |
| Quick Ratio | 6.98 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.15 |
| Debt / FCF | 0.27 |
| Interest Coverage | 134.46 |
Financial Efficiency
Return on equity (ROE) is 8.37% and return on invested capital (ROIC) is 12.62%.
| Return on Equity (ROE) | 8.37% |
| Return on Assets (ROA) | 4.50% |
| Return on Invested Capital (ROIC) | 12.62% |
| Return on Capital Employed (ROCE) | 6.76% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 603,302 |
| Profits Per Employee | 62,987 |
| Employee Count | 1,638 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 4.53 |
Taxes
In the past 12 months, SHA:603205 has paid 14.70 million in taxes.
| Income Tax | 14.70M |
| Effective Tax Rate | 12.47% |
Stock Price Statistics
The stock price has decreased by -1.23% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -1.23% |
| 50-Day Moving Average | 28.22 |
| 200-Day Moving Average | 29.11 |
| Relative Strength Index (RSI) | 45.10 |
| Average Volume (20 Days) | 864,386 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603205 had revenue of CNY 988.21 million and earned 103.17 million in profits. Earnings per share was 0.68.
| Revenue | 988.21M |
| Gross Profit | 230.35M |
| Operating Income | 102.12M |
| Pretax Income | 117.87M |
| Net Income | 103.17M |
| EBITDA | 145.77M |
| EBIT | 102.12M |
| Earnings Per Share (EPS) | 0.68 |
Balance Sheet
The company has 736.23 million in cash and 21.59 million in debt, with a net cash position of 714.64 million or 4.58 per share.
| Cash & Cash Equivalents | 736.23M |
| Total Debt | 21.59M |
| Net Cash | 714.64M |
| Net Cash Per Share | 4.58 |
| Equity (Book Value) | 1.46B |
| Book Value Per Share | 9.35 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was 138.75 million and capital expenditures -58.64 million, giving a free cash flow of 80.10 million.
| Operating Cash Flow | 138.75M |
| Capital Expenditures | -58.64M |
| Free Cash Flow | 80.10M |
| FCF Per Share | 0.51 |
Margins
Gross margin is 23.31%, with operating and profit margins of 10.33% and 10.44%.
| Gross Margin | 23.31% |
| Operating Margin | 10.33% |
| Pretax Margin | 11.93% |
| Profit Margin | 10.44% |
| EBITDA Margin | 14.75% |
| EBIT Margin | 10.33% |
| FCF Margin | 8.11% |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 0.97%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 0.97% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 40.82% |
| Buyback Yield | -30.14% |
| Shareholder Yield | -29.19% |
| Earnings Yield | 2.36% |
| FCF Yield | 1.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 9, 2025. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 9, 2025 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603205 has an Altman Z-Score of 17.09 and a Piotroski F-Score of 6.
| Altman Z-Score | 17.09 |
| Piotroski F-Score | 6 |